MyWikiBiz, Author Your Legacy — Wednesday June 26, 2024
Jump to navigationJump to search
|
|
| (5 intermediate revisions by the same user not shown) |
| Line 1: |
Line 1: |
| − | {{OMG336}} | + | {{OMG550}} |
| | | | |
| − | <feed url="http://blogsearch.google.com/blogsearch_feeds?hl=en&q=VIVUS+Inc&ie=utf-8&num=10&output=atom" entries="7"> | + | <feed url="http://blogsearch.google.com/blogsearch_feeds?hl=en&q=VIVUS+Inc+VVUS&ie=utf-8&num=10&output=atom" entries="7"> |
| | '''[{PERMALINK} {TITLE}]''' | | '''[{PERMALINK} {TITLE}]''' |
| | {DESCRIPTION} | | {DESCRIPTION} |
| Line 24: |
Line 24: |
| | | Title = | | | Title = |
| | }} | | }} |
| − | == Vivus inc (vvus) rallied 15 percent to $11 65 ==
| |
| − | the highest price since july 2010 the maker of experimental weight- loss pill qnexa said u s regulators. Vivus, inc vivus cautions you that statements included in this presentation that are not a description of historical facts are forward-looking statements. 2012 economic outlook - report highlights vivus, inc and biogen the california drug maker s weight-loss pill qnexa won the backing of an fda advisory panel as vivus seeks to gain approval for the first new obesity. Vvus quote - vvus stock quote - vivus inc stock quote - vvus snapshot quotes reflect real-time trades reported through nasdaq only comprehensive quotes reflect trading in all markets and are delayed at least 15 minutes. Vivus inc - form 8-k - ex-99 2 - november 18, 2009 hong kong -- (marketwire) -- 02/03/12 -- today, www.brightonmarkets.com announced new reports highlighting vivus, inc (nasdaq: vvus) and biogen idec inc (nasdaq: biib.
| |
| − |
| |
| − | Vivus inc announces date for fda adcom results of birth defect vivus inc has announced that the fda will hold an advisory committee meeting on february 22, 2012 for review of the obesity treatment, qnexa vivus, inc -. Vivus inc - the boston globe dec 22 (bloomberg) -- vivus inc , maker of an experimental weight-loss pill, plunged the most in 17 months after an ingredient in the medicine was shown. Vivus sinks after diet drug ingredient linked to oral clefts vvus, vivus inc - stock quote performance, technical chart analysis, smartselect ratings, group leaders and the latest company headlines. Muse (alprostadil) suppository vivus, inc description muse (alprostadil) is a single-use, medicated transurethral system for the delivery of alprostadil to the male urethra alprostadil is suspended in.
| |
| | === Share this page === | | === Share this page === |
| | <sharethis /> | | <sharethis /> |
Latest revision as of 16:34, 26 July 2012
